Human Reproduction Update, Vol.7, No.4 pp.394-403, 2001
© European Society of Human Reproduction and Embryology 2001; all rights reserved
Genetic and teratogenic effects of cancer treatments on gametes and embryos
1 Teratogen Information Service, Israel Ministry of Health and Laboratory of Teratology, Hebrew University Hadassah Medical School, Jerusalem, Israel 2 Department of Obstetrics and Gynecology, Rabin Medical Center, Petah Tiqva, Israel 3 Research Laboratory, Hadassah University Hospital, Jerusalem, Israel
To whom correspondence should be addressed at: D. Meirow, Department of Obstetrics and Gynecology, Rabin Medical Center, Petah Tiqva, Israel. e-mail: meirow{at}md2.huji.ac.il
Abstract
Male and female germ cells vary in their sensitivity to the mutagenic effects of chemotherapy and radiotherapy, depending on their stage of maturation and the agent used. Although sperm DNA damage exists following treatment, no increase in genetic defects or congenital malformations was detected among children conceived to parents who have previously undergone chemotherapy or radiotherapy. The use of assisted reproductive technologies and micromanipulation techniques might increase this risk; hence caution should be exercised. In female cancer patients, miscarriage and congenital malformations are not increased following chemotherapy. However, when IVF and embryo cryopreservation is practised between or shortly after treatment, possible genetic risks to the growing oocytes exist, and hence the babies should be screened. During pregnancy, the potential teratogenic effects of chemotherapy influence the choice and timing of therapy. Termination is usually recommended in the first trimester. Second- and third-trimester exposure does not usually increase the teratogenic risk and cognitive development, but it may increase the risk of poor obstetric outcome and fetal myelosuppression. During the first two weeks after fertilization of the embryo, radiation is lethal but not teratogenic. High doses of radiation during pregnancy induce anomalies, impaired growth and mental retardation, and there may be an increased risk of childhood leukaemia and other tumours in the offspring.
Key words: cancer / chemotherapy / radiotherapy / mutagenicity / gametes
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Carmely, D. Meirow, A. Peretz, M. Albeck, B. Bartoov, and B. Sredni Protective effect of the immunomodulator AS101 against cyclophosphamide-induced testicular damage in mice Hum. Reprod., June 1, 2009; 24(6): 1322 - 1329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Jeruss and T. K. Woodruff Preservation of Fertility in Patients with Cancer N. Engl. J. Med., February 26, 2009; 360(9): 902 - 911. [Full Text] [PDF]
|
|
|
|
 |
|
 T. T. Turner and J. J. Lysiak Oxidative Stress: A Common Factor in Testicular Dysfunction J Androl, September 1, 2008; 29(5): 488 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Perez-Crespo, P. Moreira, B. Pintado, and A. Gutierrez-Adan Factors From Damaged Sperm Affect Its DNA Integrity and Its Ability to Promote Embryo Implantation in Mice J Androl, January 1, 2008; 29(1): 47 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Lee, L. R. Schover, A. H. Partridge, P. Patrizio, W. H. Wallace, K. Hagerty, L. N. Beck, L. V. Brennan, and K. Oktay American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients J. Clin. Oncol., June 20, 2006; 24(18): 2917 - 2931. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Meirow and E. Schiff Appraisal of Chemotherapy Effects on Reproductive Outcome According to Animal Studies and Clinical Data J Natl Cancer Inst Monographs, March 1, 2005; 2005(34): 21 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Meirow, G. Assad, J. Dor, and J. Rabinovici The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice Hum. Reprod., June 1, 2004; 19(6): 1294 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Gook, D.H. Edgar, J. Borg, J. Archer, P.J. Lutjen, and J.C. McBain Oocyte maturation, follicle rupture and luteinization in human cryopreserved ovarian tissue following xenografting Hum. Reprod., September 1, 2003; 18(9): 1772 - 1781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Meseguer, N. Garrido, J. Remohi, A. Pellicer, C. Simon, J. M. Martinez-Jabaloyas, and M. Gil-Salom Testicular sperm extraction (TESE) and ICSI in patients with permanent azoospermia after chemotherapy Hum. Reprod., June 1, 2003; 18(6): 1281 - 1285. [Abstract] [Full Text] [PDF]
|
|